Michael J. Burdick

1.0k total citations
12 papers, 792 citations indexed

About

Michael J. Burdick is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Michael J. Burdick has authored 12 papers receiving a total of 792 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Pathology and Forensic Medicine and 4 papers in Oncology. Recurrent topics in Michael J. Burdick's work include Lymphoma Diagnosis and Treatment (3 papers), Viral-associated cancers and disorders (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Michael J. Burdick is often cited by papers focused on Lymphoma Diagnosis and Treatment (3 papers), Viral-associated cancers and disorders (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Michael J. Burdick collaborates with scholars based in United States and India. Michael J. Burdick's co-authors include Tilak Sundaresan, Benjamin Purow, Howard A. Fine, Jeongwu Lee, Qin Su, Raqeeb Haque, Sandra Pastorino, Irina Mikolaenko, Dragan Maric and John K. Park and has published in prestigious journals such as Cancer Research, International Journal of Radiation Oncology*Biology*Physics and Virology.

In The Last Decade

Michael J. Burdick

11 papers receiving 773 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael J. Burdick United States 9 434 207 192 166 128 12 792
C. A. Martindale United Kingdom 11 234 0.5× 163 0.8× 147 0.8× 155 0.9× 94 0.7× 15 531
Eli S. Williams United States 17 442 1.0× 125 0.6× 235 1.2× 81 0.5× 173 1.4× 40 777
Dat T. Vo United States 14 447 1.0× 295 1.4× 95 0.5× 65 0.4× 49 0.4× 45 650
Diego Carrera United States 5 305 0.7× 219 1.1× 250 1.3× 113 0.7× 386 3.0× 6 855
Jiří Šáňa Czechia 22 1.1k 2.6× 1.1k 5.2× 204 1.1× 159 1.0× 165 1.3× 65 1.6k
Mina Takahashi Japan 12 407 0.9× 137 0.7× 193 1.0× 100 0.6× 32 0.3× 48 719
Stephen H. Settle United States 15 470 1.1× 145 0.7× 310 1.6× 346 2.1× 94 0.7× 25 1.2k
Kenneth Aldape United States 9 286 0.7× 149 0.7× 120 0.6× 135 0.8× 322 2.5× 21 648
Jutaro Takahashi Japan 10 329 0.8× 125 0.6× 108 0.6× 42 0.3× 67 0.5× 46 566
Marie-Laure Arcangeli France 18 836 1.9× 159 0.8× 292 1.5× 64 0.4× 107 0.8× 29 1.5k

Countries citing papers authored by Michael J. Burdick

Since Specialization
Citations

This map shows the geographic impact of Michael J. Burdick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Burdick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Burdick more than expected).

Fields of papers citing papers by Michael J. Burdick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Burdick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Burdick. The network helps show where Michael J. Burdick may publish in the future.

Co-authorship network of co-authors of Michael J. Burdick

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Burdick. A scholar is included among the top collaborators of Michael J. Burdick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Burdick. Michael J. Burdick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Koyfman, Shlomo A., T. Djemil, Michael J. Burdick, et al.. (2011). Marginal Recurrence Requiring Salvage Radiotherapy After Stereotactic Body Radiotherapy for Spinal Metastases. International Journal of Radiation Oncology*Biology*Physics. 83(1). 297–302. 34 indexed citations
2.
Pahlajani, Geetu, Rupesh Raina, J. Stephen Jones, et al.. (2010). Early intervention with phosphodiesterase‐5 inhibitors after prostate brachytherapy improves subsequent erectile function. British Journal of Urology. 106(10). 1524–1527. 18 indexed citations
3.
Burdick, Michael J., Kevin L. Stephans, C.A. Reddy, et al.. (2010). Maximum Standardized Uptake Value From Staging FDG-PET/CT Does not Predict Treatment Outcome for Early-Stage Non–Small-Cell Lung Cancer Treated With Stereotactic Body Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 78(4). 1033–1039. 78 indexed citations
4.
Burdick, Michael J., Donald R. Neumann, Brad Pohlman, et al.. (2010). External Beam Radiotherapy Followed by 90Y Ibritumomab Tiuxetan in Relapsed or Refractory Bulky Follicular Lymphoma. International Journal of Radiation Oncology*Biology*Physics. 79(4). 1124–1130. 15 indexed citations
5.
Burdick, Michael J. & Oliver Sartor. (2010). Bone-targeted therapy in metastatic prostate cancer: osteoclast inhibitors and bone-seeking radiopharmaceuticals. Drug Discovery Today Therapeutic Strategies. 7(1-2). 23–29. 2 indexed citations
6.
Burdick, Michael J., et al.. (2009). External Beam Radiotherapy followed by Y90 Ibritumomab Tiuxetan in Relapsed Bulky Follicular Lymphoma. International Journal of Radiation Oncology*Biology*Physics. 75(3). S482–S482.
7.
Macklis, Roger M. & Michael J. Burdick. (2009). Update on the rational use of tositumomab and iodine-131 tositumomab radioimmunotherapy for the treatment of non-Hodgkin’s lymphoma. OncoTargets and Therapy. 2. 229–229. 5 indexed citations
8.
Burdick, Michael J., C.A. Reddy, James Ulchaker, et al.. (2008). Comparison of Biochemical Relapse-Free Survival Between Primary Gleason Score 3 and Primary Gleason Score 4 for Biopsy Gleason Score 7 Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 73(5). 1439–1445. 51 indexed citations
9.
Purow, Benjamin, Tilak Sundaresan, Michael J. Burdick, et al.. (2008). Notch-1 regulates transcription of the epidermal growth factor receptor through p53. Carcinogenesis. 29(5). 918–925. 96 indexed citations
10.
Burdick, Michael J., P. Jollès, Margaret M. Grimes, & Danielle Henry. (2007). Mediastinal hibernoma simulates a malignant lesion on dual time point FDG imaging. Lung Cancer. 59(3). 391–394. 11 indexed citations
11.
Purow, Benjamin, Raqeeb Haque, Martha Noel, et al.. (2005). Expression of Notch-1 and Its Ligands, Delta-Like-1 and Jagged-1, Is Critical for Glioma Cell Survival and Proliferation. Cancer Research. 65(6). 2353–2363. 458 indexed citations
12.
Delos, Sue E., Michael J. Burdick, & Judith M. White. (2002). A Single Glycosylation Site Within the Receptor-Binding Domain of the Avian Sarcoma/Leukosis Virus Glycoprotein Is Critical for Receptor Binding. Virology. 294(2). 354–363. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026